Hg’s view of the healthcare technology software space focuses on the secular growth of software suppliers for business-critical functions in the healthcare operations, core systems, life sciences, interoperability and population health sectors.

Hg has been actively following this theme for almost a decade and invested well over $1.5bn in complementary businesses across Europe and North America, with our latest investment, HHAeXchange, representing the sixth healthcare technology business currently in Hg’s portfolio, with others including, Evaluate, Intelerad, Lyniate, Medifox and MMIT. Hg recently exited its investment in Allocate, which was acquired by RLDatix.

Hg continues to be active in this sector, and is pleased to report that we have signed healthcare technology deals worth around $5 billion in Enterprise Value over just a few weeks.

Take a look at a round-up here